Form EFFECT AXIM BIOTECHNOLOGIES,
- Google lifts Nasdaq as focus turns to Fed
- Alphabet (GOOGL) Crushes Q2 Expectations to Send Shares Higher as Search and YouTube Excel, Attracts a New Street-High Price Target
- Fed maintains federal funds rate at 0 to 1/4 percent
- Apple (AAPL) Delivers Blowout Q3 Earnings but Shares Fall on Supply Chain Constraints, Analysts Still Raise PTs
- Senators reach deal on major points of U.S. infrastructure bill
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||June 22, 2021 5:00 P.M.|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SUNCREST BANK ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SBKK and Encourages Investors to Contact the Firm
- Intrommune Therapeutics Appoints Sergi Trilla, MD, MBA to its Scientific and Business Advisory Boards
- Winn-Dixie Commemorates 65 Years in Louisiana with Celebration of Community and Culture
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!